Cargando…

Investigating Carvedilol’s Repurposing for the Treatment of Non-Small Cell Lung Cancer via Aldehyde Dehydrogenase Activity Modulation in the Presence of β-Adrenergic Agonists

Repurposing existing drugs appears to be a potential solution for addressing the challenges in the treatment of non-small cell lung cancer (NSCLC). β-adrenoceptor antagonist drugs (β-blockers) have tumor-inhibiting effects, making them promising candidates for potential NSCLC treatment. This study i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ikhmais, Balqis A., Hammad, Alaa M., Abusara, Osama H., Hamadneh, Lama, Abumansour, Hamza, Abdallah, Qasem M., Ibrahim, Ali I. M., Elsalem, Lina, Awad, Mariam, Alshehada, Rahaf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605277/ https://www.ncbi.nlm.nih.gov/pubmed/37886948 http://dx.doi.org/10.3390/cimb45100505

Ejemplares similares

Conducting COVID-19-Related Research in Jordan: Are We Ready?
por: Ikhmais, Balqis, et al.
Publicado: (2020)

Preparation and Characterization of Capsaicin Encapsulated Polymeric Micelles and Studies of Synergism with Nicotinic Acids as Potential Anticancer Nanomedicines
por: Shamsheer, Rawan, et al.
Publicado: (2023)

Synthesis of microwave-assisted carboxamides in Triton WR-1339-induced hyperlipidemic rats: possible hypolipidemic heterocyclic compounds
por: Al-Jammal, Basmah, et al.
Publicado: (2023)

The Role of Vitamin E in Protecting against Oxidative Stress, Inflammation, and the Neurotoxic Effects of Acute Paracetamol in Pregnant Female Rats
por: Hammad, Alaa M., et al.
Publicado: (2023)

Carvedilol Prevents Redox Inactivation of Cardiomyocyte Β(1)-Adrenergic Receptors
por: Park, Misun, et al.
Publicado: (2018)

MARCH2 promotes endocytosis and lysosomal sorting of carvedilol-bound β(2)-adrenergic receptors
por: Han, Sang-oh, et al.
Publicado: (2012)

Carvedilol ameliorates dexamethasone-induced myocardial injury in rats independent of its action on the α1-adrenergic receptor
por: Mohamed, Rasha M. S. M., et al.
Publicado: (2022)

Targeting Human Proteins for Antiviral Drug Discovery and Repurposing Efforts: A Focus on Protein Kinases
por: Hajjo, Rima, et al.
Publicado: (2023)

Impact of R-Carvedilol on β2-Adrenergic Receptor-Mediated Spontaneous Calcium Release in Human Atrial Myocytes
por: Casabella-Ramón, Sergi, et al.
Publicado: (2022)

Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of measures
por: Vinik, Aaron I., et al.
Publicado: (2014)

Effect of adrenergic blockers, carvedilol, prazosin, metoprolol and combination of prazosin and metoprolol on paracetamol-induced hepatotoxicity in rabbits
por: Zubairi, Maysaa B., et al.
Publicado: (2014)

Repurposing Carvedilol as a Novel Inhibitor of the Trypanosoma cruzi Autophagy Flux That Affects Parasite Replication and Survival
por: Rivero, Cynthia Vanesa, et al.
Publicado: (2021)

Enantioselective Resolution of (R,S)-Carvedilol to (S)-(−)-Carvedilol by Biocatalysts
por: Ettireddy, Swetha, et al.
Publicado: (2017)

In Vitro Evaluation of ALDH1A3-Affinic Compounds on Breast and Prostate Cancer Cell Lines as Single Treatments and in Combination with Doxorubicin
por: Abusara, Osama H., et al.
Publicado: (2023)

Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of clinical results
por: Bloom, Heather L., et al.
Publicado: (2014)

Gα(i) is required for carvedilol-induced β(1) adrenergic receptor β-arrestin biased signaling
por: Wang, Jialu, et al.
Publicado: (2017)

Effect of beta‐adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial
por: Clark, Andrew L., et al.
Publicado: (2017)

Carvedilol improves glucose tolerance and insulin sensitivity in treatment of adrenergic overdrive in high fat diet-induced obesity in mice
por: Nguyen, Linh V., et al.
Publicado: (2019)

Development and optimization of carvedilol orodispersible tablets: enhancement of pharmacokinetic parameters in rabbits
por: Aljimaee, Yazeed HM, et al.
Publicado: (2015)

Carvedilol in hypertension treatment
por: Stafylas, Panagiotis C, et al.
Publicado: (2008)

Carvedilol—NSBB of Choice in All Cirrhotics? Short Title: Carvedilol for Portal Hypertension
por: Tandon, Puneeta, et al.
Publicado: (2015)

Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial
por: Kveiborg, Britt, et al.
Publicado: (2007)

Microemulsions as Lipid Nanosystems Loaded into Thermoresponsive In Situ Microgels for Local Ocular Delivery of Prednisolone
por: Hamed, Rania, et al.
Publicado: (2022)

Clinical value of detecting autoantibodies against β(1)-, β(2),- and α(1)-adrenergic receptors in carvedilol treatment of patients with heart failure
por: Hou, Dong-Yan, et al.
Publicado: (2020)

Use of carvedilol in hypertension: an update
por: Leonetti, Gastone, et al.
Publicado: (2012)

Carvedilol in the Treatment of Portal Hypertension
por: Al-Ghamdi, Hamdan
Publicado: (2011)

The Adrenergic Receptor Antagonist Carvedilol Elicits Anti-Tumor Responses in Uveal Melanoma 3D Tumor Spheroids and May Serve as Co-Adjuvant Therapy with Radiation
por: Farhoumand, Lina S., et al.
Publicado: (2022)

Prospects for repurposing CNS drugs for cancer treatment
por: Abdelaleem, Mohamed, et al.
Publicado: (2019)

Carvedilol, an Adrenergic Blocker, Suppresses Melanin Synthesis by Inhibiting the cAMP/CREB Signaling Pathway in Human Melanocytes and Ex Vivo Human Skin Culture
por: Choi, Myoung Eun, et al.
Publicado: (2020)

Selected Statins as Dual Antiproliferative-Antiinflammatory Compounds
por: Hussein, Buchra Haj, et al.
Publicado: (2022)

Preclinical Evidences for an Antimanic Effect of Carvedilol
por: de Souza, Greicy Coelho, et al.
Publicado: (2015)

Carvedilol for the treatment of red scrotum syndrome
por: Merhi, Ribal, et al.
Publicado: (2017)

Hot Melt Coating of Amorphous Carvedilol
por: Bannow, Jacob, et al.
Publicado: (2020)

Unique Positive Cooperativity Between the β-Arrestin–Biased β-Blocker Carvedilol and a Small Molecule Positive Allosteric Modulator of the β2-Adrenergic Receptor
por: Pani, Biswaranjan, et al.
Publicado: (2021)

In silico drug repurposing carvedilol and its metabolites against SARS-CoV-2 infection using molecular docking and molecular dynamic simulation approaches
por: Zhang, Chunye, et al.
Publicado: (2023)

The Neuroprotective Effect of Carvedilol on Diabetic Neuropathy: An In Vitro Study
por: Magadmi, Rania M., et al.
Publicado: (2021)

A simple LC-MS/MS method for pharmacokinetic study of carvedilol and 4/-hydroxyphenyl carvedilol at a low dose
por: Eiamart, Wanna, et al.
Publicado: (2022)

Repurposing beta-3 adrenergic receptor agonists for Alzheimer’s disease: beneficial effects in a mouse model
por: Tournissac, Marine, et al.
Publicado: (2021)

Effect of hydroxylpropyl-β-cyclodextrin on Solubility of Carvedilol
por: Shewale, B. D., et al.
Publicado: (2008)

Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol
por: Barold, S. Serge, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gv0mkcvf4o0cputaa8omshuk8e